Picture of RIZAP logo

2928 — RIZAP News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMid CapNeutral

Brief: Rizap Group unit to jointly conduct randomized controlled trial

Aug 7 (Reuters) - Rizap Group Inc  2928.SP   
     
     
    * Says unit plans to joint conduct randomized controlled 
trial related to sarcopenia prevention of stomach cancer 
perioperative period with partner, from Sept. 1  
 
     
    Source text in Japanese:https://goo.gl/ZzJ975 
    Further company coverage: 2928.SP  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111; 
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))

Recent news on RIZAP

See all news